# Hypofractionated WPPT With HDR Boost

> **NCT06591819** · PHASE2 · RECRUITING · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 30 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** Hypofractionated Whole Pelvis Proton Therapy with Brachytherapy Boost

## Key facts

- **NCT ID:** NCT06591819
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-15
- **Primary completion:** 2034-01
- **Final completion:** 2035-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06591819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06591819, "Hypofractionated WPPT With HDR Boost". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06591819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*